MIM
NYMX

Macroview Investment Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Macroview Investment Management’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-550
Closed -$4K – 228
2013
Q3 		$4K Hold
550
– – 0.01% 164
2013
Q2 		$3K Buy
+550
New +$2.79K ﹤0.01% 130

Other funds holding NYMX

Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Macroview Investment Management's NYMX Position: Q4 2013 in Review

Macroview Investment Management sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2013, closing a stake of 550 shares — an estimated $4K sold.

Macroview Investment Management first reported a position in NYMX in Q2 2013 and held it in 2 quarters. The position peaked at $4K in Q3 2013. 32 funds tracked by Wall St. Rank hold NYMX as of Q4 2013.

  • Macroview Investment Management reported no remaining Nymox Pharmaceutical Corp position as of Q4 2013 after selling out during the quarter.
  • Macroview Investment Management sold 550 Nymox Pharmaceutical Corp shares in Q4 2013, an estimated $4K.
  • Macroview Investment Management first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 2 quarters.
  • Macroview Investment Management's Nymox Pharmaceutical Corp position peaked at $4K in Q3 2013.
  • 32 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2013.

Based on Macroview Investment Management's 13F filing for Q4 2013, filed 6 Feb 2014.